Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +48.68%
#3 DOVU DOVU +48.00%
#4 Velvet Velvet +44.04%
#5 Black Phoenix Black Phoenix +34.47%
#6 Perle Perle +19.03%
#7 Cross Cross +18.07%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.92%
#9 Ο„emplar Ο„emplar +16.86%
#10 Ribbita by Virtuals Ribbita by Virtuals +15.85%
Coin of the day
Glidr Glidr
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Evofem Biosciences, Inc. Evofem Biosciences, Inc.

Evofem Biosciences, Inc.

EVFM
Kedudukan dalam Saham #38406
Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated... Evofem Biosciences, Inc. operates as a biopharmaceutical enterprise dedicated to innovating and bringing to market treatments that address critical underserved areas in women's sexual and reproductive health. Their leading commercial offering is Phexxi, a vaginal gel specifically designed as a contraceptive. Additionally, the company is actively advancing EVO100, an antimicrobial vaginal gel under development, intended to prevent the urogenital spread of both Chlamydia trachomatis and Neisseria gonorrhoeae infections in women. The company's main office is situated in San Diego, California.
Harga Saham
$0.007524
Modal Pasaran
$997.16K
Perubahan (1 hari)
-5.95%
Perubahan (1 tahun)
-22.43%
Negara
US
Perdagangan Evofem Biosciences, Inc. (EVFM)

Kategori

Healthcare
Hasil untuk Evofem Biosciences, Inc. (EVFM)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Evofem Biosciences, Inc., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Evofem Biosciences, Inc. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE